Mortality Among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors
Name:
Articulpublicado.pdf
Size:
635.1Kb
Format:
PDF
Description:
Versión articulo publicado
Name:
EstadopublicacionArticulo.pdf
Size:
483.6Kb
Format:
PDF
Description:
Estado publicación
Name:
Tesiscompletareyvisiones.pdf
Size:
1.499Mb
Format:
PDF
Description:
Articulo con revisiones
Name:
Articulpublicado.epub
Size:
407.6Kb
Format:
application/epub
Description:
Articulo formato ePUB
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2015-02-14
Metadata
Show full item recordOther Titles
Tuberculosis sensible y drogorresistente: Mortalidad y sus factores asociadosCitation
10.1371/journal.pone.01193321. Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, Bernabe-Ortiz A. Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors. Caylà JA, editor. PLoS One [Internet]. 2015 Mar 19 [cited 2017 Jun 12];10(3):e0119332. Available from: http://dx.plos.org/10.1371/journal.pone.0119332
Publisher
PLoS ONEJournal
PLoS ONEAbstract
Background: An increase in multidrug-resistant tuberculosis (MDR-TB) cases is evident worldwide. Its management implies a complex treatment, high costs, more toxic anti-tuberculosis drug use, longer treatment time and increased treatment failure and mortality. The aims of this study were to compare mortality between MDR and drug-susceptible cases of tuberculosis, and to determine risk factors associated with mortality among MDR-TB cases. Methods and Results: A retrospective cohort study was performed using data from clinical records of the National Strategy for Prevention and Control of Tuberculosis in Lima, Peru. In the first objective, MDR-TB, compared to drug-susceptible cases, was the main exposure variable and time to death, censored at 180 days, the outcome of interest. For the second objective, different variables obtained from clinical records were assessed as potential risk factors for death among MDR-TB cases. Cox regression analysis was used to determine hazard ratios (HR) and 95% confidence intervals (95%CI). A total of 1,232 patients were analyzed: mean age 30.9 ±14.0 years, 60.0% were males. 61 patients (5.0%) died during treatment, whereas the MDR-TB prevalence was 19.2%. MDR-TB increased the risk of death during treatment (HR=7.5; IC95%: 4.1–13.4) when compared to presumed drug-susceptible cases after controlling for potential confounders. Education level (p=0.01), previous TB episodes (p<0.001), diabetes history (p<0.001) and HIV infection (p=0.04) were factors associated with mortality among MDR-TB cases. Conclusions: MDR-TB is associated with an increased risk of death during treatment. Lower education, greater number of previous TB episodes, diabetes history, and HIV infection were independently associated with mortality among MDR-TB cases. New strategies for appropriate MDR-TB detection and management should be implemented, including drug sensitivity tests, diabetes and HIV screening, as well as guarantee for a complete adherence to therapy.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/openAccessLanguage
engDescription
[email protected][email protected]
[email protected]
Artículo de revista que fue aceptada para publicación en la Revista PLOS ONE el 03 de Febrero de 2015.
EISSN
1932-6203Collections
The following license files are associated with this item: